A
ATEA PHARMACEUTICALS INC
NASDAQ: AVIR (Atea Pharmaceuticals, Inc.)
Kemas kini terakhir: 18 minit lalu4.29
-0.12 (-2.72%)
| Penutupan Terdahulu | 4.41 |
| Jumlah Dagangan | 34,794 |
| Harga / Buku (P/B) | 1.65 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -1.65 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.35% |
| Nisbah Semasa (MRQ) | 19.94 |
| Aliran Tunai Operasi (OCF TTM) | -126.20 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -37.46 M |
| Pulangan Atas Aset (ROA TTM) | -12.77% |
| Pulangan Atas Ekuiti (ROE TTM) | -30.47% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Atea Pharmaceuticals, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Nilai 35% | 0.0 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | 0.0 |
| Masa 35% | -0.2 |
| AI Technical info | NA |
| Osilator Teknikal info | -2.0 |
| Purata Bergerak Teknikal info | 2.5 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Persekitaran | ×1.21 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -17.9% |
| Persetujuan Tonggak | ×1.00 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | -1.1 |
| Skor Akhir | -0.08 |
|
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 11.79% |
| % Dimiliki oleh Institusi | 66.86% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Bml Capital Management, Llc | 30 Sep 2026 | 6,753,658 |
| Rosalind Advisors, Inc. | 30 Jun 2026 | 1,070,550 |
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |